BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology Today - ECPv6.16.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology Today
X-ORIGINAL-URL:https://oncologynewstoday.co.uk
X-WR-CALDESC:Events for Oncology Today
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250220
DTEND;VALUE=DATE:20250223
DTSTAMP:20250128T155112Z
CREATED:20250128T155112Z
LAST-MODIFIED:20250128T155112Z
UID:6924-1740009600-1740268799@oncologynewstoday.co.uk
SUMMARY:EASL Liver Cancer Summit 2025
DESCRIPTION:The 2025 EASL Liver Cancer Summit in Paris\, is the premier event for liver cancer research and practice. \nRecent advancements in primary liver cancer\, particularly in treatment strategies for hepatocellular carcinoma and cholangiocarcinoma\, have transformed the field. \nImmunotherapy and new systemic therapies are challenging established treatment paradigms\, while artificial intelligence is enhancing diagnostic capabilities. \nWith rapid innovations and new therapeutic targets emerging\, this summit is essential for staying at the forefront of liver cancer research and treatment. \nWe eagerly anticipate welcoming you to Paris on 20-22 February 2025.
URL:https://oncologynewstoday.co.uk/event/easl-liver-cancer-summit-2025/
LOCATION:Le Palais des Congrès d’Issy.\, Paris\, France
CATEGORIES:Oncology Events
END:VEVENT
END:VCALENDAR